P

Inventor

LIU DONGLEI

US12 patents
⚠️ This page may combine multiple inventors who share the name “LIU DONGLEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARTMAN III GERALD DAVID

6 patents
US8501756B2Aug 6, 2013

Heterobicyclic carboxamides as inhibitors for kinases

ARTMAN III GERALD DAVID65 citations96
US8242125B2Aug 14, 2012

Heterobicyclic carboxamides as inhibitors for kinases

ARTMAN III GERALD DAVID3 citations61
US8541432B2Sep 24, 2013

Heterobicyclic carboxamides as inhibitors for kinases

ARTMAN III GERALD DAVID0 citations50
US8492393B2Jul 23, 2013

Heterobicyclic carboxamides as inhibitors for kinases

ARTMAN III GERALD DAVID0 citations50
US8486954B2Jul 16, 2013

Heterobicyclic carboxamides as inhibitors for kinases

ARTMAN III GERALD DAVID0 citations50
US8431584B2Apr 30, 2013

Heterobicyclic carboxamides as inhibitors for kinases

ARTMAN III GERALD DAVID0 citations50

BAYER PHARMACEUTICALS CORP

2 patents
US6900205B2May 31, 2005

1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders

BAYER PHARMACEUTICALS CORP19 citations90
US7109196B2Sep 19, 2006

1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders

BAYER PHARMACEUTICALS CORP7 citations71

NOVARTIS AG

2 patents
US11845730B2Dec 19, 2023

1,3-substituted cyclobutyl derivatives and uses thereof

NOVARTIS AG2 citations72
US12084442B2Sep 10, 2024

Naphthyridinone derivatives for the treatment of a disease or disorder

NOVARTIS AG0 citations46

BAUSCH & LOMB IRELAND LTD

1 patent
US12435040B2Oct 7, 2025

1,3-substituted cyclobutyl derivatives and uses thereof

BAUSCH & LOMB IRELAND LTD0 citations61

ADAMS CHRISTOPHER M

1 patent
US9765067B2Sep 19, 2017

Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators

ADAMS CHRISTOPHER M0 citations38